Medicare Enrolled
Dr. Anthony Victorio, M.D.
Cytopathology Physician · Modesto, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Victorio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Victorio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Victorio
Dr. Anthony Victorio is a cytopathology physician in Modesto, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Victorio performed 7,451 Medicare services across 5,294 unique beneficiaries.
Between the years covered by Open Payments, Dr. Victorio received a total of $189 from 4 pharmaceutical and/or device companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Victorio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$189 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,451
Medicare services
Top 1% in CA for cytopathology physician
5,294
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~414 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
2,499 | $33 | $126 |
| Automated cervical cancer screening with manual review A cervical or vaginal sample is prepared using an automated thin-layer system. The sample is screened by an automated system and then manually rescreened under physician supervision. |
980 | $26 | $290 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
644 | $34 | $135 |
| HPV high-risk type test for cervical cancer screening This test detects high-risk types of human papillomavirus (HPV) DNA or RNA. It is used for cervical cancer screening and must be performed in addition to a Pap test. |
344 | $34 | $72 |
| COVID-19 viral test, high throughput A laboratory test to detect the SARS-CoV-2 virus using high-throughput technology. This test identifies multiple types or subtypes of the virus and is performed by non-CDC laboratories. |
294 | $74 | $200 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
279 | $34 | $130 |
| Vaginal fluid RNA bacterial test A laboratory test that measures the RNA of bacteria found in a vaginal fluid specimen. |
228 | $140 | $290 |
| COVID-19 nucleic acid test, high throughput A laboratory test that detects the genetic material of the SARS-CoV-2 virus using amplified probe techniques. This method utilizes high-throughput technologies to process samples efficiently. |
226 | $24 | $50 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
188 | $34 | $135 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
188 | $34 | $135 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 183 | $20 | $65 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
167 | $58 | $337 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
144 | $64 | $327 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
134 | $76 | $227 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
104 | $141 | $417 |
| Moderately high complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation. |
90 | $69 | $190 |
| Automated Pap test with manual rescreening A cervical cancer screening test using an automated system to prepare the sample, followed by a manual review to check for abnormalities. |
84 | $26 | $260 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
67 | $43 | $139 |
| Tissue preparation to remove calcium A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination. |
66 | $10 | $35 |
| Fine needle aspirate evaluation and report A pathologist examines cells collected via a fine needle aspiration and provides a written interpretation and report of the findings. |
59 | $59 | $200 |
| Additional Pap test evaluation episode An additional immediate evaluation of a fine needle aspirate sample during a Pap test procedure. |
58 | $19 | $30 |
| Fine needle aspirate evaluation A laboratory examination of cells collected via fine needle aspiration to assess for abnormalities. |
57 | $30 | $140 |
| Limited pathology tissue examination A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis. |
56 | $4 | $45 |
| HPV high-risk type nucleic acid test A laboratory test that uses nucleic acid detection to identify high-risk types of human papillomavirus. |
49 | $34 | $131 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
45 | $62 | $367 |
| Blood smear interpretation with written report A physician examines a blood sample slide under a microscope to analyze blood cells. The doctor provides a written report of their findings. |
34 | $19 | $70 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
30 | $24 | $79 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
29 | $88 | $275 |
| Bone marrow smear interpretation A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities. |
26 | $57 | $200 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
21 | $288 | $815 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
20 | $52 | $212 |
| Pap test, manual screening A laboratory test in which a healthcare provider manually examines a sample of cells from the cervix under a microscope to check for abnormalities. |
17 | $20 | $65 |
| High complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope using advanced techniques to analyze cellular details. |
16 | $124 | $1,020 |
| Microscopic tissue examination A pathologist examines a tissue sample under a microscope to identify abnormalities or disease. |
13 | $6 | $80 |
| Intraoperative pathology examination of specimen A pathology test performed during surgery to examine a tissue sample from the initial site. The results help guide the surgeon's immediate decisions. |
12 | $53 | $420 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2023 ↗$189
Total received (2019-2023)
Avg $47/year across 4 years
Top 36% in CA for cytopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
4
Companies
6
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$189 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$34
2022
$40
2021
$16
2019
$101
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$19
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2019-2023) ›
Foundation Medicine, Inc.
$101
Merck Sharp & Dohme LLC
$54
Lilly USA, LLC
$19
Merck Sharp & Dohme Corporation
$16
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
FOUNDATIONONE · KEYTRUDA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cytopathology physicians within 10 mi
14
Per 100K population
2.5
County median income
$79,661
Nearest hospital
DOCTORS MEDICAL CENTER
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Victorio is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Victorio experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Victorio performed 2,499 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Victorio receive payments from pharmaceutical companies?
Yes. Dr. Victorio received a total of $189 from 4 companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Victorio's costs compare to other cytopathology physicians in Modesto?
Dr. Victorio's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Victorio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cytopathology Physicians in Modesto
Browse cytopathology physicians in Modesto ranked by procedure volume and transparency data.
Highest volume
Top Cytopathology Physicians in CA
Cytopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cytopathology Physicians in CA
Which CA cytopathology physicians receive the most from drug and device companies.
By company
Foundation Medicine, Inc. Payments to Doctors
See all physicians who received payments from Foundation Medicine, Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology